Cohort profile: Multicenter Networks for Ideal Outcomes of Rare Pediatric Endocrine and Metabolic Diseases in Korea (OUTSPREAD study)
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Rare endocrine diseases are complex conditions that require lifelong specialized care due to their chronic nature and associated long-term complications. In Korea, a lack of nationwide data on clinical practice and outcomes has limited progress in patient care. Therefore, the Multicenter Networks for Ideal Outcomes of Pediatric Rare Endocrine and Metabolic Disease (OUTSPREAD) study was initiated. This study involves 30 centers across Korea. The study aims to improve the long-term prognosis of Korean patients with rare endocrine diseases by collecting comprehensive clinical data, biospecimens, and patient-reported outcomes to identify complications and unmet needs in patient care. Patients with childhood-onset pituitary, adrenal, or gonadal disorders, such as craniopharyngioma, congenital adrenal hyperplasia (CAH), and Turner syndrome were prioritized. The planned enrollment is 1,300 patients during the first study phase (2022–2024). Clinical, biochemical, and imaging data from diagnosis, treatment, and follow-up during 1980–2023 were retrospectively reviewed. For patients who agreed to participate in the prospective cohort, clinical data and biospecimens will be prospectively collected to discover ideal biomarkers that predict the effectiveness of disease control measures and prognosis. Patient-reported outcomes, including quality of life and depression scales, will be evaluated to assess psychosocial outcomes. Additionally, a substudy on CAH patients will develop a steroid hormone profiling method using liquid chromatography-tandem mass spectrometry to improve diagnosis and monitoring of treatment outcomes. This study will address unmet clinical needs by discovering ideal biomarkers, introducing evidence-based treatment guidelines, and ultimately improving long-term outcomes in the areas of rare endocrine and metabolic diseases.
Abstract
Rare endocrine diseases are complex conditions that require lifelong specialized care due to their chronic nature and associated long-term complications. In Korea, a lack of nationwide data on clinical practice and outcomes has limited progress in patient care. Therefore, the Multicenter Networks for Ideal Outcomes of Pediatric Rare Endocrine and Metabolic Disease (OUTSPREAD) study was initiated. This study involves 30 centers across Korea. The study aims to improve the long-term prognosis of Korean patients with rare endocrine diseases by collecting comprehensive clinical data, biospecimens, and patient-reported outcomes to identify complications and unmet needs in patient care. Patients with childhood-onset pituitary, adrenal, or gonadal disorders, such as craniopharyngioma, congenital adrenal hyperplasia (CAH), and Turner syndrome were prioritized. The planned enrollment is 1,300 patients during the first study phase (2022–2024). Clinical, biochemical, and imaging data from diagnosis, treatment, and follow-up during 1980–2023 were retrospectively reviewed. For patients who agreed to participate in the prospective cohort, clinical data and biospecimens will be prospectively collected to discover ideal biomarkers that predict the effectiveness of disease control measures and prognosis. Patient-reported outcomes, including quality of life and depression scales, will be evaluated to assess psychosocial outcomes. Additionally, a substudy on CAH patients will develop a steroid hormone profiling method using liquid chromatography-tandem mass spectrometry to improve diagnosis and monitoring of treatment outcomes. This study will address unmet clinical needs by discovering ideal biomarkers, introducing evidence-based treatment guidelines, and ultimately improving long-term outcomes in the areas of rare endocrine and metabolic diseases.
참고문헌 (25)
- Otte A, "Childhood-onset craniopharyngioma", J Clin Endocrinol Metab, 106, pp.e3820~e3836 (2021)
- Claahsen-van der Grinten HL, "Congenital adrenal hyperplasia-current insights in pathophysiology, diagnostics, and management", Endocr Rev, 43, pp.91~159 (2022)
- Gravholt CH, "The changing face of Turner syndrome", Endocr Rev, 44, pp.33~69 (2023)
- Ahmid M, "Childhood-onset growth hormone deficiency and the transition to adulthood : current perspective", Ther Clin Risk Manag, 14, pp.2283~2291 (2018)
- Kim JH, "Diagnosis and treatment of growth hormone deficiency : a position statement from Korean Endocrine Society and Korean Society of Pediatric Endocrinology", Endocrinol Metab(Seoul), 35, pp.272~287 (2020)
- Gan HW, "National UK guidelines for the management of paediatric craniopharyngioma", Lancet Diabetes Endocrinol, 11, pp.694~706 (2023)
- Speiser PW, "Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency : an Endocrine Society Clinical Practice Guideline", J Clin Endocrinol Metab, 103, pp.4043~4088 (2018)
- Gravholt CH, "Clinical practice guidelines for the care of girls and women with Turner syndrome", Eur J Endocrinol, 190, pp.G53~G151 (2024)
- Sterkenburg AS, "Survival, hypothalamic obesity, and neuropsychological", psychosocial status after childhood-onset craniopharyngioma : newly reported longterm outcomes, 2015, pp.17, 1029~1038
- Yau M, "Health-related quality of life in children with congenital adrenal hyperplasia", Horm Res Paediatr, 84, pp.165~171 (2015)
- Liedmeier A, "Psychosocial well-being and quality of life in women with Turner syndrome", Psychoneuroendocrinology, 113, pp.104548~ (2020)
- Park SH, "The effect of hypothalamic involvement and growth hormone treatment on cardiovascular risk factors during the transition period in patients with childhood-onset craniopharyngioma", Ann Pediatr Endocrinol Metab, 28, pp.107~115 (2023)
- Kim JH, "Long-term consequences of congenital adrenal hyperplasia due to classic 21-hydroxylase deficiency in adolescents and adults", Exp Clin Endocrinol Diabetes, 125, pp.196~201 (2017)
- Lim SG, "Long-term health outcomes of Korean adults with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency", Front Endocrinol(Lausanne), 12, pp.761258~ (2021)
- Park SY, "Neurocognitive and psychosocial profiles of children with Turner syndrome", Ann Pediatr Endocrinol Metab, 28, pp.258~266 (2023)
- Boekhoff S, "Long-term effects of growth hormone replacement therapy in childhood-onset craniopharyngioma : results of the German Craniopharyngioma Registry(HIT-Endo)", Eur J Endocrinol, 179, pp.331~341 (2018)
- Tseretopoulou X, "The I-CAH Registry : a platform for international collaboration for improving knowledge and clinical care in congenital adrenal hyperplasia", Clin Endocrinol(Oxf), 101, pp.397~404 (2024)
- Kanakatti Shankar R, "Inspiring new science to guide healthcare in Turner syndrome : rationale, design, and methods for the InsighTS Registry", Am J Med Genet A, 194, pp.311~319 (2024)
- Ali SR, "The current landscape of European registries for rare endocrine conditions", Eur J Endocrinol, 180, pp.89~98 (2019)
- Kim JH, "The 2017 Korean National Growth Charts for children and adolescents : development, improvement, and prospects", Korean J Pediatr, 61, pp.135~149 (2018)
- Varni JW, "The PedsQL 4. 0 as a pediatric population health measure : feasibility, reliability, and validity", Ambul Pediatr, 3, pp.329~341 (2003)
- Kovacs M, "Encyclopedia clinical psychology", pp.1~5 (2014), Wiley
- Lee EH, "Reliability and validity of the Beck Depression Inventory-II among Korean adolescents", Psychiatry Investig, 14, pp.30~36 (2017)
- Brouwer WB, "The CarerQol instrument : a new instrument to measure carerelated quality of life of informal caregivers for use in economic evaluations", Qual Life Res, 15, pp.1005~1021 (2006)
- Lee EH, "Korean versions of the Perceived Stress Scale(PSS-14, 10 and 4) : psychometric evaluation in patients with chronic disease", Scand J Caring Sci, 29, pp.183~192 (2015)